Physician profile
Lance I Kovar
NPI 1225057599
$5,702.89
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,571 · 2020: $1,075 · 2021: $739 · 2022: $318.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,802.67 | 2019-2021 | |
| Medical Device Business Services, INC. | $1,392.68 | 2019 | |
| Edwards Lifesciences Corporation | $782.13 | 2019-2022 | |
| Medtronic Vascular, INC. | $758.56 | 2019-2020 | |
| Medtronic, INC. | $190.53 | 2021-2022 | |
| Boston Scientific Corporation | $148.96 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $148.47 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $108.53 | 2019 | |
| Welch Allyn | $81.50 | 2021 | |
| Atricure, INC. | $40.57 | 2019 | |
| Chiesi USA, INC. | $40.23 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $39.25 | 2019 | |
| Cardinal Health 200 LLC | $38.49 | 2019 | |
| Angiodynamics, INC. | $34.61 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.08 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.10 | 2019 | |
| Portola Pharmaceuticals, LLC | $15.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.63 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $13.00 | 2019 | |
| Amarin Pharma, INC. | $12.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Kovar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.